Tadnersen | Interleukin Related interleukin-related.com

Product Name :
Tadnersen

Search keywords :
Tadnersen (sodium)

drugId :
null

Target Vo:
Guanine nucleotide exchange C9orf72

Target Vo Short Name :
C9orf72

Moa_Name:
Guanine nucleotide exchange C9orf72 modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ionis Pharmaceuticals Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Amyotrophic Lateral Sclerosis

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
IL-6R Antibody Autophagy
PKR Rabbit mAb Biological Activity
FGFR2/CD332 Antibody: FGFR2/CD332 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 92 kDa, targeting to FGFR2/CD332. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts